cobalt has been researched along with Atherogenesis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Fong, TH; Tsui, L | 1 |
| Anderson, R; Asano, T; Baumbach, A; Johnson, T; Kiemeneij, F; Lansky, AJ; Onuma, Y; Serruys, PW; Slagboom, T; Van Royen, N; Vlachojannis, G; Wijns, W; Xu, B; Zheng, M | 1 |
| Buadze, TZh; Dzhokhadze, TA; Gaiozishvili, MN; Kakauridze, NG; Lezhava, TA | 1 |
| Bauskin, AR; Breit, SN; Brown, DA; Jiang, L; Luo, XW; Wu, L | 1 |
| Ari, E; Beytur, A; Demir, H; Gecit, I; Kaspar, C; Kaya, Y | 1 |
| Gray, WA; Molnar, RG | 1 |
| KHODZHAEV, AKh; KOCHERGINA, NZ | 1 |
2 trial(s) available for cobalt and Atherogenesis
| Article | Year |
|---|---|
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic le
Topics: Atherosclerosis; Chromium; Cobalt; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Europe; Humans; Neointima; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome | 2018 |
Sustained patency and clinical improvement following treatment of atherosclerotic iliac artery disease using the Assurant cobalt iliac balloon-expandable stent system.
Topics: Aged; Angioplasty, Balloon; Atherosclerosis; Cobalt; Equipment Design; Female; Humans; Iliac Artery; Male; Prospective Studies; Remission Induction; Stents; Vascular Patency | 2013 |
5 other study(ies) available for cobalt and Atherogenesis
| Article | Year |
|---|---|
Cobalt Chloride Induces Macrophage Foam Cell Formation: A Chemical Hypoxia Model for Anti-Atherosclerotic Drug Screening.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cell Hypoxia; Cells, Cultured; Cobalt; Drug Evaluation, Preclinical; Macrophages; Mice; Models, Biological; RAW 264.7 Cells | 2021 |
[Genomic instability in atherosclerosis].
Topics: Adult; Age Factors; Aged, 80 and over; Atherosclerosis; Chromatin; Chromosome Aberrations; Cobalt; Female; Genomic Instability; Humans; Lymphocytes; Male; Mutation; Oligopeptides | 2014 |
The TGF-beta superfamily cytokine MIC-1/GDF15: secretory mechanisms facilitate creation of latent stromal stores.
Topics: Arthritis, Rheumatoid; Atherosclerosis; Cell Differentiation; Cell Hypoxia; Cloning, Molecular; Cobalt; Growth Differentiation Factor 15; Humans; Immunization; Lipopolysaccharides; Macrophages; Neoplasms; Protein Processing, Post-Translational; Secretory Pathway; Transforming Growth Factor beta; Transgenes; Tretinoin; U937 Cells | 2010 |
Serum cadmium levels are independently associated with endothelial function in hemodialysis patients.
Topics: Adult; Atherosclerosis; Cadmium; Case-Control Studies; Cobalt; Copper; Endothelium; Female; Humans; Iron; Lead; Linear Models; Magnesium; Male; Manganese; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Spectrophotometry, Atomic; Trace Elements; Zinc | 2012 |
[Treatment of atherosclerosis with Co No. 8].
Topics: Atherosclerosis; Cobalt | 1962 |